The Late News Abstract Submission Deadline is February 26, 2024 at 6 PM PST.
ABSTRACT SUBMISSION NOTES:
Abstracts are limited to 1830 characters (including spaces, but not including title, authors and affiliations).
The Abstract Submission Fee is $75 for Student Members and $100 for all other submissions. Abstract fees are non-refundable.
Be sure to have your AChemS membership number (or the membership number of your sponsor) prior to starting the abstract submission process.
Abstracts submitted for late news will only be considered for poster
presentation and are not eligible to receive abstract awards.
POSTER PRESENTERS: The poster display boards will accommodate posters up to 42 in wide x 40 in high (half sized posters). Push pins and poster board numbers will be provided.
POSTER + SHORT SYMPOSIUM PRESENTATION: Four - six oral abstracts will be chosen for short talks during symposium sessions. Each presenter will give talks of 12 minutes (plus 3 minutes for questions). In addition to an oral presentation, authors will also have the option of presenting their abstract as a poster.
SYMPOSIA PRESENTERS: Symposia will follow a standard format. Each will begin with a short introduction (2 minutes) given by the symposium chair. Symposia will include five (5) invited speakers. Four will give talks of 20 minutes (plus 5 minutes for questions). A short talk of 15 minutes (plus 3 minutes for questions) is designated for graduate students, postdoctoral fellows or junior faculty and maybe selected from abstract submissions.
ABSTRACT ELIGIBILITY RULES
Each abstract must be sponsored by a member of AChemS. A member of AChemS may sponsor only one abstract.
An individual may appear as first author on only one abstract and may present only one abstract at the
meeting; the first author does not have to be a member.
It is the responsibility of the presenting author and sponsor to ensure that all authors have given their consent to be listed on the submitted version of the abstract. If the presenting author/sponsor is found to be in violation of this rule, they may not be allowed to submit abstracts at future meetings.
The work in the abstract should represent new and original research conducted by the authors.
To facilitate scientific communication, abstracts reporting studies with unidentified drugs, chemical compounds, or materials will not be accepted. All drugs, chemical compounds, and materials should be identified both in the abstract and during the meeting.